Non-segmental Vitiligo Clinical Trial
Official title:
Topical Ruxolitinib Evaluation in Vitiligo Study 1 (TRuE-V1): A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Extension Period in Participants With Vitiligo
The purpose of this study is to evaluate the efficacy and safety of ruxolitinib cream in adolescent and adult participants with non-segmental vitiligo for whom total body involved vitiligo area (facial and nonfacial) does not exceed 10% body surface area (BSA).
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04057573 -
Topical Ruxolitinib Evaluation in Vitiligo Study 2 (TRuE-V2)
|
Phase 3 | |
| Completed |
NCT04942860 -
The Evaluation of Vitiligous Lesions Repigmentation After Topical Administration of Methotrexate in Patients With Active Vitiligo
|
Phase 3 | |
| Recruiting |
NCT06113328 -
A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007)
|
Phase 2 | |
| Recruiting |
NCT01377077 -
Punchgrafting Techniques for Vitiligo
|
Phase 4 | |
| Completed |
NCT04927975 -
Study to Evaluate Adverse Events and Change in Disease Activity With Oral Tablets of Upadacitinib in Adult Participants With Non-Segmental Vitiligo
|
Phase 2 | |
| Completed |
NCT04487860 -
Efficacy and Safety of AS012 in Subjects With Non-segmental Vitiligo
|
Phase 2 | |
| Active, not recruiting |
NCT04811326 -
Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation
|
Phase 4 | |
| Terminated |
NCT03022019 -
ReNovaCell in Non-segmental Vitiligo
|
N/A | |
| Completed |
NCT03247400 -
The Evaluation of Vitiligous Lesions Repigmentation After the Administration of Atorvastatin Calcium Salt and Simvastatin-acid Sodium Salt in Patients With Active Vitiligo
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05990309 -
ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO
|
N/A |